Contineum Therapeutics (CTNM) Research & Development (2023 - 2024)
Historic Research & Development for Contineum Therapeutics (CTNM) over the last 2 years, with Q4 2024 value amounting to $13.0 million.
- Contineum Therapeutics' Research & Development rose 6244.38% to $13.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $38.4 million, marking a year-over-year increase of 3919.5%. This contributed to the annual value of $38.4 million for FY2024, which is 3919.5% up from last year.
- Per Contineum Therapeutics' latest filing, its Research & Development stood at $13.0 million for Q4 2024, which was up 6244.38% from $9.7 million recorded in Q3 2024.
- In the past 5 years, Contineum Therapeutics' Research & Development ranged from a high of $13.0 million in Q4 2024 and a low of $3.6 million during Q1 2023